investorscraft@gmail.com

Intrinsic ValueIDEX Biometrics ASA (0MTP.L)

Previous Close£5.70
Intrinsic Value
Upside potential
Previous Close
£5.70

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

IDEX Biometrics ASA operates in the biometric authentication sector, specializing in fingerprint recognition technology for secure payment and access control applications. The company focuses on smart cards, particularly in financial payment systems, where its solutions enhance security for contactless transactions and digital currency storage. Serving manufacturers in the biometric payment card market, IDEX positions itself as a niche player in a high-growth segment driven by increasing demand for secure, frictionless authentication. The company’s technology targets financial institutions, access control providers, and digital wallet developers, leveraging its proprietary fingerprint sensor designs. Despite competition from larger semiconductor firms, IDEX differentiates through its dedicated focus on biometric smart cards, a market expected to expand with the global shift toward cashless payments. Its geographic reach spans Europe, the Americas, and Asia-Pacific, though it remains a smaller-scale operator compared to diversified tech giants in the biometrics space.

Revenue Profitability And Efficiency

In FY 2023, IDEX reported revenue of NOK 4.15 million, reflecting its early-stage commercialization efforts in a capital-intensive industry. The company posted a net loss of NOK 26.7 million, with negative operating cash flow of NOK 27.9 million, underscoring ongoing investment needs. Capital expenditures were modest at NOK 243,768, suggesting a lean operational approach amid R&D and market penetration challenges.

Earnings Power And Capital Efficiency

IDEX’s diluted EPS of -1.07 NOK highlights its pre-profitability status, typical of a growth-focused biometrics firm. The negative operating cash flow and reliance on external funding indicate limited near-term earnings power, though the company’s technology could gain traction as biometric payment cards gain adoption. Capital efficiency remains constrained by high development costs relative to current revenue scale.

Balance Sheet And Financial Health

As of December 2023, IDEX held NOK 11.4 million in cash against total debt of NOK 6.96 million, providing limited liquidity. The balance sheet reflects a high-risk profile common to developmental-stage tech firms, with negative equity likely necessitating further financing to sustain operations. Debt levels are manageable but warrant monitoring given persistent cash burn.

Growth Trends And Dividend Policy

Revenue growth potential hinges on broader adoption of biometric payment cards, though FY 2023 sales remain nominal. The company does not pay dividends, reinvesting all resources into R&D and market expansion. Long-term prospects depend on securing partnerships with card manufacturers and financial institutions to scale production.

Valuation And Market Expectations

With a market cap of NOK 237 million and a beta of 1.84, IDEX is priced as a high-volatility speculative play. Investors appear to discount near-term fundamentals in favor of optionality around biometric payment card adoption. The valuation reflects optimism about future market penetration rather than current financial performance.

Strategic Advantages And Outlook

IDEX’s focus on fingerprint authentication for payment cards provides a differentiated niche, but execution risks are high given competition and adoption timelines. Success depends on securing design wins with major card manufacturers and achieving cost-competitive mass production. The outlook remains uncertain, with upside tied to industry-wide biometric card adoption accelerating.

Sources

Company filings, London Stock Exchange data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount